Filing Details

Accession Number:
0001384101-17-000064
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-20 16:46:15
Reporting Period:
2017-10-18
Accepted Time:
2017-10-20 16:46:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588970 H Bonnie Anderson 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-18 6,000 $2.36 16,000 No 4 M Direct
Common Stock Disposition 2017-10-18 6,000 $9.09 10,000 No 4 S Direct
Common Stock Acquisiton 2017-10-20 10,000 $2.68 20,000 No 4 M Direct
Common Stock Disposition 2017-10-20 10,000 $9.60 10,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-10-18 6,000 $2.36 6,000 $2.36
Common Stock Stock Option (right to buy) Disposition 2017-10-20 10,000 $2.68 10,000 $2.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
47,086 2020-09-28 No 4 M Direct
129,219 2022-03-10 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 99,085 Indirect The Bonnie H. Anderson Living Trust
Footnotes
  1. The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017.
  2. Represents weighted average sales price. Sale prices for the transactions range from $8.82 to $9.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  3. Actual sales price.
  4. The option becomes exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
  5. The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.